Products Categories
CAS No.: | 100299-08-9 |
---|---|
Name: | Pemirolast potassium |
Article Data: | 3 |
Molecular Structure: | |
Formula: | C10H7KN6O |
Molecular Weight: | 266.303 |
Synonyms: | Pemirolast potassium salt;TBX;TBX(pharmaceutical);4H-Pyrido[1,2-a]pyrimidin-4-one,9-methyl-3-(1H-tetrazol-5-yl)-, potassium salt (9CI);Alamast;Alegysal;BMY26517;Pemilaston; |
Melting Point: | 310-311 °C (dec.) |
Boiling Point: | 454.8 °C at 760 mmHg |
Flash Point: | 228.9 °C |
Solubility: | Water (Slightly) |
Appearance: | crystalline solid |
PSA: | 77.97000 |
LogP: | -0.03120 |
What can I do for you?
Get Best Price
The Pemirolast potassium with CAS registry number of 100299-08-9 is also known as Pemirolast potassium salt. The IUPAC name is Potassium 9-methyl-3-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)pyrido[1,2-a]pyrimidin-4-one. It belongs to product categories of Anti-Allergic; Bases & Related Reagents; Heterocycles; Intermediates & Fine Chemicals; Nucleotides; Pharmaceuticals. In addition, the formula is C10H7KN6O and the molecular weight is 266.30. This chemical is a crystalline solid. What's more, it can be used as a inhibitor of chemical mediator and antiallergic.
Physical properties about Pemirolast potassium are: (1)ACD/LogP: -0.02; (2)ACD/LogD (pH 5.5): -1.14; (3)ACD/LogD (pH 7.4): -1.98; (4)ACD/BCF (pH 5.5): 1; (5)ACD/BCF (pH 7.4): 1; (6)ACD/KOC (pH 5.5): 1.75; (7)ACD/KOC (pH 7.4): 1; (8)#H bond acceptors: 7; (9)#H bond donors: 1; (10)#Freely Rotating Bonds: 1; (11)Flash Point: 228.9 °C; (12)Enthalpy of Vaporization: 71.45 kJ/mol; (13)Boiling Point: 454.8 °C at 760 mmHg; (14)Vapour Pressure: 1.85E-08 mmHg at 25 °C.
You can still convert the following datas into molecular structure:
1. Canonical SMILES: CC1=CC=CN2C1=NC=C(C2=O)C3=NN=N[N-]3.[K+]
2. InChI: InChI=1S/C10H7N6O.K/c1-6-3-2-4-16-9(6)11-5-7(10(16)17)8-12-14-15-13-8;/h2-5H,1H3;/q-1;+1
3. InChIKey: NMMVKSMGBDRONO-UHFFFAOYSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
dog | LD50 | oral | > 6gm/kg (6000mg/kg) | Drugs in Japan Vol. -, Pg. 1259, 1995. | |
mouse | LD50 | intraperitoneal | 511mg/kg (511mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992. | |
mouse | LD50 | intravenous | 220mg/kg (220mg/kg) | Japanese Kokai Tokyo Koho Patents. Vol. #95-69895, | |
mouse | LD50 | oral | 1185mg/kg (1185mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992. | |
mouse | LD50 | subcutaneous | 543mg/kg (543mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992. | |
rat | LD50 | intravenous | 372mg/kg (372mg/kg) | Japanese Kokai Tokyo Koho Patents. Vol. #95-69895, | |
rat | LD50 | oral | 687mg/kg (687mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992. | |
rat | LD50 | subcutaneous | 430mg/kg (430mg/kg) | Iyakuhin Kenkyu. Study of Medical Supplies. Vol. 23, Pg. 682, 1992. |